Dr Reddy's Laboratories share price logo

Dr Reddy's Laboratories

NYSE: RDY

Large Cap

$14.89

+0.06

(+0.40%)

as on

Dr Reddy's Laboratories Stock Performance

as on November 21, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $14.86
    $15.09
    downward going graph

    0.20%

    Downside

    1.34%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $11.36
    $15.67
    downward going graph

    23.71%

    Downside

    5.24%

    Upside

    downward going graph

Dr Reddy's Laboratories share price movements today

Previous Close
$14.83
Open
$14.93
Volume
908.9K
Market Cap
$12.5B
Dividend Yield
0.75%
Day's Low - High
$14.86 - $15.09
52 Week Low - High
$11.36 - $15.67

Dr Reddy's Laboratories Historical Returns

1 Month Return
+ 12.89 %
3 Month Return
+ 22.25 %
1 Year Return
+ 7.05 %
3 Year Return
+ 9.05 %
5 Year Return
+ 19.43 %

Dr Reddy's Laboratories Stock Fundamentals & Key Indicators

Check Dr Reddy's Laboratories market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$12.5B

EPS (TTM)

34.01

Dividend Yield

0.75%

Quarterly Earnings Growth YOY

-0.36%

PE Ratio (TTM)

41.69

Industry PE ratio

18.71

PEG Ratio

-0.80

EBITDA

54.0B

Revenue (TTM)

331.4B

Profit Margin

49.49%

Return On Equity TTM

7.37%

Dr Reddy's Laboratories vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Dr Reddy's Laboratories with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Neutral$12.5B19.43%41.6949.49%0.75%
Buy$42.4BNA64.6947.54%1.06%
StrongBuy$24.6B177.98%20.2186.34%0.00%
Buy$22.8B50.08%-37.5135.22%2.41%
Buy$39.2BNA18.8565.57%1.37%

Stock Returns calculator for Dr Reddy's Laboratories Stock including INR - Dollar returns

The Dr Reddy's Laboratories stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Dr Reddy's Laboratories investment value today

Current value as on today

₹1,10,662

Returns

₹10,662

(+10.66%)

Returns from Dr Reddy's Laboratories Stock

₹7,045 (+7.05%)

Dollar Impact

₹3,617 (+3.62%)

Analyst Recommendation on Dr Reddy's Laboratories Stock

Based on 1 analysts

HOLD

0.00%

Buy

100.00%

Hold

0.00%

Sell

Based on 1 analysts, 100% of analysts recommend a 'HOLD' rating for Dr Reddy's Laboratories. Average target price of $14.92

Dr Reddy's Laboratories Share Price Target

Get share price movements and forecasts by analysts on Dr Reddy's Laboratories.

What analysts predicted

0.2%UPSIDE

Target Price

$14.92

Current Price

$14.89

Analyzed by

1 Analysts

High

$14.14512

Target

$14.92

Low

$14.14512

Dr Reddy's Laboratories target price $14.92, a slight upside of 0.2% compared to current price of $14.89. According to 1 analysts rating.

Indian Investors' Interest in Dr Reddy's Laboratories Stock

Search interest for Dr Reddy's Laboratories Stock has increased by 22% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:22% versus previous 30 day period

Dr Reddy's Laboratories Quarterly Profit & Loss

All numbers in Millions USD

Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Total Revenue
76,727
80,162
83,586
85,060
85,452
88,051
87,268
76,331
81,183
86,594
Gross Profit
46,344
47,769
49,052
47,263
48,627
48,140
46,806
34,215
37,762
45,144
Operating Income
17,925
17,551
18,720
17,647
17,475
17,513
14,238
473
2,971
11,878
EBITDA
21,757
23,899
24,279
25,264
24,642
24,308
19,722
8,758
8,343
17,140
Interest Expense
598
757
818
656
830
907
951
1,073
1,262
1,246
Depreciation
3,810
3,975
4,719
4,554
4,765
5,051
5,213
5,662
5,372
5,262
Income Before Tax
18,821
19,167
18,742
20,054
19,047
18,350
15,429
2,021
5,558
12,260
Income Tax Expense
4,901
5,752
4,704
4,182
4,951
4,082
3,533
-217
1,184
3,138
Net Income
13,920
12,553
14,133
15,938
14,178
14,372
12,098
2,235
4,461
9,237
Net Profit Margin
60.40%
59.59%
58.68%
55.56%
56.91%
54.67%
53.63%
44.82%
46.52%
52.13%

Dr Reddy's Laboratories Annual Profit & Loss

All numbers in Millions USD

Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Total Revenue
140,809
142,028
153,851
174,600
2,555
214,391
245,879
279,164
325,535
353,471
Gross Profit
78,356
76,304
83,430
94,009
1,297
113,840
139,343
163,607
190,428
186,518
Operating Income
13,498
11,917
20,888
15,993
431
29,476
57,144
67,729
71,843
48,867
EBITDA
24,548
23,735
35,522
41,785
13,158
45,080
74,431
88,422
96,671
83,293
Interest Expense
634
788
889
13
970
958
1,428
1,711
2,829
3,933
Depreciation
11,277
11,710
12,190
12,472
12,796
11,824
12,636
14,841
17,058
21,681
Income Before Tax
14,653
14,341
22,443
18,032
355
32,298
60,367
71,870
76,784
57,678
Income Tax Expense
2,614
4,535
3,648
-1,466
123
8,730
15,300
16,186
19,539
12,995
Net Income
12,039
9,806
18,795
19,498
232
23,568
45,067
55,684
56,544
45,087
Net Profit Margin
55.65%
53.72%
54.23%
53.84%
50.78%
53.10%
56.67%
58.61%
58.50%
52.77%

Dr Reddy's Laboratories Quarterly Cash Flow

All numbers in Millions USD

Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Net Income
13,920
13,415
14,038
15,872
14,096
14,268
11,897
2,235
4,348
9,237
Operating Cash Flow
8,496
9,316
6,620
21,996
14,629
15,573
10,908
15,437
-927
4,692
Investing Cash Flow
-20,248
-19,071
-5,458
-13,300
-19,192
-9,543
-10,292
-28,222
3,836
3,648
Financing Cash Flow
9,541
16,150
590
-7,370
-1,203
-5,323
7,777
8,738
-7,117
-6,319
Change in Cash
-2,194
6,372
1,747
1,561
-5,589
902
8,751
-4,234
-4,169
1,943

Dr Reddy's Laboratories Annual Cash Flow

All numbers in Millions USD

Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Net Income
12,039
9,806
18,795
19,498
17,238
23,568
45,067
55,684
57,245
45,087
Operating Cash Flow
21,513
18,029
28,704
29,841
35,703
28,108
58,875
45,433
46,428
56,645
Investing Cash Flow
-18,471
-14,883
-7,727
-4,923
-22,660
-26,387
-41,373
-40,283
-58,077
-70,533
Financing Cash Flow
-3,692
-4,440
-21,326
-25,159
-298
-2,422
-26,861
-3,763
18,911
13,395
Change in Cash
-1,142
-1,237
-314
-266
12,858
32
-9,073
1,328
7,486
-875

Global Institutional Holdings in Dr Reddy's Laboratories

Check out the Institutions with significant holdings in Dr Reddy's Laboratories.

Funds
Holdings
Shares Held
BlackRock, Inc.
1.10%
9169667
AB Funds
0.41%
3386923
Vanguard
0.37%
3100911
DFA INVESTMENT DIMENSIONS GROUP INC
0.33%
2754709
VANGUARD INTERNATIONAL EQUITY INDEX FUNDS
0.27%
2226840

Dr Reddy's Laboratories News & Key Events

  • img

    Today's Timeline - 26 October

    Mon, 12:50 PM

    -

    Dr. Reddy's stock price target raised to $13.42, implying 2% upside; consensus rating remains Hold.

    Mon, 03:50 PM

    -

    Dr. Reddy's stock price target raised to $13.55, implying 3% upside; consensus rating shifts to Buy.

    Mon, 04:17 PM

    -

    Dr. Reddy's Q2 earnings miss estimates; revenues decline 1.5% year over year due to lower lenalidomide sales.

  • img

    Today's Timeline - 26 October

    Mon, 07:47 PM

    -

    Dr. Reddy's files unmodified auditor review for September 2026 interim results, confirming compliance with accounting standards.

Insights on Dr Reddy's Laboratories

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 3 quarters, 76.33B → 86.59B (in $), with an average increase of 6.1% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 3 quarters, 2.23B → 9.23B (in $), with an average increase of 50.8% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, RDY stock has moved up by 1.0%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Viatris Inc. Common Stock has given 87.7% return, outperforming this stock by 80.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, SANDOZ GROUP AG SPONSORED ADS Switzerland has given 109.5% return, outperforming this stock by 99.5%

About Dr Reddy's Laboratories

Established in 1984 and headquartered in Hyderabad, India, Dr. Reddy's Laboratories Limited functions as a fully integrated global pharmaceutical entity. Its business is structured into several core divisions. The Global Generics segment is responsible for the production and distribution of prescription and over-the-counter finished pharmaceutical products, marketed either under their own brand names or as generic versions therapeutically equivalent to branded formulations, also encompassing biologics. The Pharmaceutical Services and Active Ingredients (PSAI) division manufactures and supplies active pharmaceutical ingredients (APIs) and intermediates, which are fundamental components for finished drugs, alongside offering contract research services and custom production of APIs and steroids. The Proprietary Products segment is dedicated to the research and development of unique and differentiated drug formulations. Furthermore, its "Others" segment focuses on developing treatments for oncology and inflammatory conditions. The company's therapeutic reach spans numerous areas including gastro-intestinal, cardiovascular, anti-diabetic, dermatological, oncology, respiratory, stomatological, urological, and nephrological health. Dr. Reddy's also maintains a strategic collaboration with Curis, Inc., centered on the discovery, development, and commercialization of small molecule antagonists for immuno-oncology and precision oncology applications.
OrganisationDr Reddy's Laboratories
Headquarters8-2-337, Road No. 3, Hyderabad, TS, 500034, IN
IndustryDrug Manufacturers - Specialty & Generic
CEOErez Israeli

Key Management of Dr Reddy's Laboratories

Name

Title

Mr. Kallam Satish Reddy B.Tech., M.S.

Chairman of the Board & Member of the Management Council

Mr. Erez Israeli M.B.A.

CEO & Member of the Management Council

Mr. Mannam Venkatanarasimham

CFO & Member of the Management Council

Mr. Krishna K. Venkatesh B.Pharma M.S.

Global Head of IPDO, Integrated Product Development & Member of the Management Council

Mr. Gunupati Venkateswara Prasad B.E.

Co-Chairman, MD & Member of Management Council

FAQs

What is Dr Reddy's Laboratories share price today?

Dr Reddy's Laboratories share price today is $14.89 as on at the close of the market. Dr Reddy's Laboratories share today touched a day high of $15.09 and a low of $14.86.

What is the 52 week high and 52 week low for Dr Reddy's Laboratories share?

Dr Reddy's Laboratories share touched a 52 week high of $15.67 on and a 52 week low of $11.36 on . Dr Reddy's Laboratories stock price today i.e. is closed at $14.89,which is 4.98% down from its 52 week high and 31.07% up from its 52 week low.

What is Dr Reddy's Laboratories's market capitalisation today?

Dr Reddy's Laboratories market capitalisation is $0.01T as on .

How to invest in Dr Reddy's Laboratories Stock (RDY) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Dr Reddy's Laboratories on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Dr Reddy's Laboratories Stock (RDY) from India?

Indian investors can start investing in Dr Reddy's Laboratories (RDY) shares with as little as ₹92.66999816894531 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹926.70 in Dr Reddy's Laboratories stock (as per the Rupee-Dollar exchange rate as on ). Based on Dr Reddy's Laboratories share’s latest price of $14.89 as on November 21, 2026 at 8:46 am IST, you will get 0.6716 shares of Dr Reddy's Laboratories. Learn more about fractional shares .

What are the returns that Dr Reddy's Laboratories has given to Indian investors in the last 5 years?

Dr Reddy's Laboratories stock has given 19.43% share price returns and 25.55% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?